| Dr Gregory Frank Florey Pereira, MD | |
|
1915 Randolph Rd, Charlotte, NC 28207 | |
| (704) 323-2426 | |
| Not Available |
| Full Name | Dr Gregory Frank Florey Pereira |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 1915 Randolph Rd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063918944 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2023-00935 (North Carolina) | Primary |
| Entity Name | Carolinas Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774333 PECOS PAC ID: 4789597477 Enrollment ID: O20031110000116 |
News Archive
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.
A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.
BioTrends Research Group, Inc. recently published its TreatmentTrends: Vascular Access report. This report is based on online survey results from over 150 physicians (general nephrologists, surgeons, interventional radiologists and interventional nephrologists).
› Verified 3 days ago
| Entity Name | Orthocarolina, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497704217 PECOS PAC ID: 2062316821 Enrollment ID: O20031122000126 |
News Archive
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.
A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.
BioTrends Research Group, Inc. recently published its TreatmentTrends: Vascular Access report. This report is based on online survey results from over 150 physicians (general nephrologists, surgeons, interventional radiologists and interventional nephrologists).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Frank Florey Pereira, MD 4601 Park Rd, Ste 300, Charlotte, NC 28209 Ph: () - | Dr Gregory Frank Florey Pereira, MD 1915 Randolph Rd, Charlotte, NC 28207 Ph: (704) 323-2426 |
News Archive
The largest prospective trial ever examining the anti-inflammatory drug Vioxx as a chemoprevention agent found that the risk of developing a cardiovascular "event" - heart attacks and/or strokes - was almost double in patients who received the drug, compared to patients who took the placebo, according to a study out Feb. 15 on-line in The New England Journal of Medicine.
The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.
A component has been identified by researchers in Umeå as a novel regulator of the immune system. It acts as a molecular switch to deactivate the innate immune system and has the ability to prevent certain diseases caused by an excessive activation of the immune system.
BioTrends Research Group, Inc. recently published its TreatmentTrends: Vascular Access report. This report is based on online survey results from over 150 physicians (general nephrologists, surgeons, interventional radiologists and interventional nephrologists).
› Verified 3 days ago
Laurence Byron Kempton, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1025 Morehead Medical Dr, Ste 300, Charlotte, NC 28204 Phone: 704-446-2060 | |
Dr. Amanda Nicole Fletcher, MD, MSCR Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2001 Vail Ave Ste 200b, Charlotte, NC 28207 Phone: 704-323-3668 | |
Daniel Joseph Hurwit, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1915 Randolph Rd, Charlotte, NC 28207 Phone: 704-323-3003 | |
Dr. Alfred Leonard Rhyne Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2001 Randolph Rd, Charlotte, NC 28207 Phone: 704-323-2000 | |
Dr. Eric Brian Laxer, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2001 Randolph Rd, Charlotte, NC 28207 Phone: 704-323-2000 | |
Dr. Ronald Wayne Singer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15825 John J Delaney Dr, Suite 100, Charlotte, NC 28277 Phone: 704-323-2000 | |
James Ferrigan Fraser, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4741 Randolph Rd Ste 100, Charlotte, NC 28211 Phone: 704-365-6730 Fax: 704-365-6731 |